Purpose To compare the diagnostic performance and clinical utility of three MRI protocols for detecting clinically significant prostate cancer (csPCa) according to prebiopsy risk. Materials and Methods This retrospective study included 390 male patients who underwent prostate multiparametric MRI (mpMRI) between January...
A. Ponsiglione, L. Cereser, M. De Martino et al.· Radiology: Imaging Cancer· 0 citations
A narrative review summarizes the principles, clinical applications, strengths, and limitations of the main prostate imaging scoring systems currently in use and incorporates artificial intelligence, hybrid PET/MRI, and combined clinical-genomic biomarkers, together with prospective multicenter validation, to advance p...
E. Messina, A. Borrelli, G. Agrotis et al.· BJR|Open· 0 citations
Prostate-specific antigen (PSA)-based screening for prostate cancer (PCa) remains controversial due to uncertain long-term benefits, overdiagnosis, and overtreatment of indolent disease. Magnetic resonance imaging (MRI) has transformed the diagnostic pathway of PCa and is increasingly explored as a screening tool. This...
G. Brembilla, E. Messina, T. Barret et al.· European Radiology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.